Mechanisms of quinolone resistance

Journal of Infection and Chemotherapy

Volumn 3, Issue 3, 1997, Pages 128-138

  Nakamura, Shinichi ^a,b  

^a DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

^b GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Gyrase; Mechanism; Permeability; Quinolone; Resistance; Topoisomerase IV

Indexed keywords

EID: 0001403583     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02491502     Document Type: Review

References (31)

1. Satake S. Yearly change of drug susceptibility (1983-1992). In: Medical Information System Developing Center (eds) Drug susceptibility information 1993. Tokyo: Yakugyojihosha, 1993:45-57 (in Japanese).
2. Goldstein FW, Acar JF. Epidemiology of quinolone resistance: Europe and North and South America. Drugs 1995;49(suppl 2):36-42.
3. Turnidge J. Epidemiology of quinolone resistance: Eastern hemisphere. Drugs 1995;49(suppl 2):43-47.
4. Konno M, Ubukata K. Present status of quinolone resistance. In: UedaY, Shimizu K, Konno M, Matsumoto F (eds) Quinolones.Tokyo: Life Science, 1991:75-84 (in Japanese).
5. Courvalin P. Plasmid-mediated 4-quinolone resistance: a real or apparent absence? Antimicrob Agents Chemother 1990;34:681-684.
6. Gellert M, Mizuuchi K, O'Dea MH, Nash HA. DNA gyrase: an enzyme that introduces superhelical turns into DNA. Proc Natl Acad Sci USA 1976;73:3872-3876.
7. Gellert M. DNA topoisomerases. Annu Rev Biochem 1981;50:879-910.
8. Wang JC. DNA topoisomerases. Annu Rev Biochem 1985;54:665-697.
9. Wang JC. DNA topoisomerases. Annu Rev Biochem 1996;65:635-692.
10. 2 core. Biochemistry 1980;19:5229-5234.
11. Swanberg SL, Wang JC. Cloning and sequencing of the Escherichia coli gyrA gene coding for the A subunit of DNA gyrase. J Mol Biol 1987;197:723-736.
12. Hussain K, Elliot EJ, Salmond GPC. The ParD mutant of Escherichia coli also carries a gyrAam mutation. The complete sequence of gyrA Mol Microbiol 1987;1:259-273.
13. Yoshida H, Kojima T, Yamagishi J, Nakamura S. Quinolone-resistant mutations of the gyrA gene of Escherichia coli. Mol Gen Genet 1988;211:1-7.
14. Yamagishi J,Yoshida H, Yamayoshi M, Nakamura S. Nalidixic acid-resistant mutations of the gyrB gene of Escherichia coli. Mol Gen Genet 1986;204:367-373.
15. Adachi T, Mizuuchi M, Robinson EA, Appella E, O'Dea MH, Gellert M, Mizuuchi K. DNA sequence of the E. coli gyrB gene: application of a new sequencing strategy. Nucleic Acids Res 1987;15:771-784.
16. Sugino A, Cozzarelli NR. The intrinsic ATPase of DNA gyrase. J Biol Chem 1980;255:6299-6306.
17. Maxwell A, Gellert M. Mechanistic aspects of DNA topoisomerases. Adv Protein Chem 1986;38:69-107.
18. Gellert M, Mizuuchi K, O'Dea MH, Itoh T, Tomizawa J. Nalidixic acid resistance: a second genetic character involved in DNA gyrase activity. Proc Natl Acad Sci USA 1977;74:4772-4776.
19. Sugino A, Peebles CL, Kreuzer KN, Cozzarelli NR. Mechanism of action of nalidixic acid: purification of Escherichia coli nalA gene product and its relationship to DNA gyrase and a novel nicking and closing enzyme. Proc Natl Acad Sci USA 1977;74:4767-4771.
20. Gellert M, O'Dea MH, Itoh T, Tomizawa J. Novobiocin and coumermycin inhibit DNA supercoiling catalyzed by DNA gyrase. Proc Natl Acad Sci USA 1976;73:4474-4478.
21. Yamagishi J,Yoshida H,Yamayoshi M, Nakamura S. Nalidixic acid-resistant mutations of the gyrB gene of Escherichia coli. Mol Gen Genet 1986;204:367-373.
22. Yoshida H, Bogaki M, Nakamura M, Nakamura S. Quinolone resistance- determining region in the DNA gyrase gyrA gene of Escherichia coli. Antimicrob Agents Chemother 1990;34:1271-1272.
23. Nakamura S, Nakamura M, Kojima T,Yoshida H. gyrA and gyrB mutations in quinolone-resistant strains of Escherichia coli. Antimicrob Agents Chemother 1989;33:254-255.
24. Cambau E, Borden F, Collatz E, Gutmann L. Novel gyrA point mutation in a strain of Escherichia coli resistant to fluoroquinolones but not to nalidixic acid. Antimicrob Agents Chemother 1993;37:1247-1252.
25. Cullen ME, Wyke AW, Kuroda R, Fisher LM. Cloning and characterization of a DNA gyrase A gene from Escherichia coli that confers clinical resistance to 4-quinolones. Antimicrob Agents Chemother 1989;33:886-894.
26. Heisig P, Schedletzky H, Falkenstein-Paul H. Mutations in the gyrA gene of a highly fluoroquinolone-resistant clinical isolate of Escherichia coli. Antimicrob Agents Chemother 1993;37:696-701.
27. Oram M, Fisher LM. 4-Quinolone resistance mutations in the DNA gyrase of Escherichia coli clinical isolates identified by using the polymerase chain reaction. Antimicrob Agents Chemother 1991;35:387-389.
28. Vila J, Ruiz J, Marco F, Barcelo A, Goni P, Giralt E, De Anta TJ. Association between double mutation in the gyrA gene of ciprofloxacin resistant clinical isolates of Escherichia coli and MICs. Antimicrob Agents Chemother 1994;38: 2477-2479.
29. Truong QC , Van J-CN, Shlaes D, Gutmann L, Moreau NJ. A novel, double mutation in DNA gyrase A of Escherichia coli conferring resistance to quinolone antibiotics. Antimicrob Agents Chemother 1997;41:85-90.
30. Griggs DJ, Gensberg K, Piddock LJV. Mutations in gyrA gene of quinolone- resistant Salmonella serotypes isolated from humans and animals. Antimicrob Agents Chemother 1996;40:1009-1013.
31. Reyna F, Huesca M, Gonzalez V, Fuchs LY. Salmonella typhimurium gyrA mutations associated with fluoroquinolone resistance. Antimicrob Agents Chemother 1995;39:1621-1623.